NASDAQ:TCRX

Tscan Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy TCRX

*Your capital is at risk

$0.97

-0.0080 (-0.82%)

At Close: Jun 03, 2026

TScan Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 87.71. In total, the insiders bought 30.05M and sold 329.37K TCRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	87.71
● Buy	30.05M shares
● Sell	329.37K shares
98% Buy Activity Weak Negative Correlation
Buy Signal High Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 87.71. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 26, 2024 Buy	Pre-funded Warrant (right to buy) P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	7 500 000 Value: $750
Dec 26, 2024 Buy	Pre-funded Warrant (right to buy) P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	7 500 000 Value: $750
Dec 13, 2024 Buy	Common Stock P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	100 000 Value: $290.1K
Dec 13, 2024 Buy	Common Stock P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	100 000 Value: $290.1K
Dec 12, 2024 Buy	Common stock, $0.0001 par value per share ("Common Stock") P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	31 800 Value: $95.6K
Dec 12, 2024 Buy	Common stock, $0.0001 par value per share ("Common Stock") P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	31 800 Value: $95.6K
Nov 15, 2024 Buy	Common stock, $0.0001 par value per share P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	947 Value: $4K
Nov 15, 2024 Buy	Common stock, $0.0001 par value per share P-Purchase	Lynx1 Capital Management Lp 10 Percent Owner	10% Owner	947 Value: $4K
Sep 23, 2024 Buy	Voting Common Stock P-Purchase	Klencke Barbara Director	Director	5 000 Value: $26.5K
Sep 23, 2024 Buy	Voting Common Stock P-Purchase	Klencke Barbara Director	Director	5 000 Value: $26.5K
Aug 26, 2024 Buy	Voting Common Stock P-Purchase	Klencke Barbara Director	Director	5 000 Value: $27.7K
Aug 26, 2024 Buy	Voting Common Stock P-Purchase	Klencke Barbara Director	Director	5 000 Value: $27.7K
Aug 23, 2024 Buy	Voting Common Stock P-Purchase	Klencke Barbara Director	Director	5 000 Value: $28.5K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	64 166 Value: $159.8K
Aug 23, 2024 Buy	Voting Common Stock M-Exempt	Zdraveski Zoran See Remarks	Officer	64 166 Value: $159.8K
Aug 23, 2024 Buy	Voting Common Stock M-Exempt	Zdraveski Zoran See Remarks	Officer	13 125 Value: $23.8K
Aug 23, 2024 Buy	Voting Common Stock M-Exempt	Zdraveski Zoran See Remarks	Officer	25 000 Value: $81.8K
Aug 23, 2024 Buy	Voting Common Stock M-Exempt	Zdraveski Zoran See Remarks	Officer	54 895 Value: $266.2K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	54 895 Value: $266.2K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	25 000 Value: $81.8K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	13 125 Value: $23.8K
Aug 23, 2024 Sell	Voting Common Stock S-Sale	Zdraveski Zoran See Remarks	Officer	164 686 Value: $952.1K
Aug 23, 2024 Sell	Voting Common Stock S-Sale	Zdraveski Zoran See Remarks	Officer	164 686 Value: $952.1K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	13 125 Value: $23.8K
Aug 23, 2024 Buy	Stock Option (Right to Buy) M-Exempt	Zdraveski Zoran See Remarks	Officer	25 000 Value: $81.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks